Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.3%

9 terminated/withdrawn out of 123 trials

Success Rate

89.9%

+3.4% vs industry average

Late-Stage Pipeline

9 trials in Phase 3/4

Results Transparency

0 of 80 completed trials have results

Key Signals

15 recruiting9 withdrawn

Enrollment Performance

Analytics

N/A

54(74.0%)

Phase 2

7(9.6%)

Phase 3

6(8.2%)

Phase 4

3(4.1%)

Early Phase 1

3(4.1%)

73Total

N/A(54)

Phase 2(7)

Phase 3(6)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (123)

Showing 20 of 123 trials

NCT06292377Not ApplicableRecruiting

Better Understanding of Fatigue After STroke

Role: lead

NCT07413315Not ApplicableRecruiting

Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.

Role: lead

NCT04333797Not ApplicableCompleted

Psychiatry of Transition in a World in Transition

Role: collaborator

NCT07267416Not ApplicableRecruiting

Impact of Combined PSi + NIRS Monitoring in the Prevention of Postoperative Cognitive Disorders in Cardiac Surgery.

Role: lead

NCT07267403Not ApplicableRecruiting

Comparison of Modulations of Motor Brain Activity and SedLine After Median Nerve Stimulation in General Anesthesia

Role: lead

NCT02143986Recruiting

Glycosylated Ferritin in Macrophagic Activation Syndromes

Role: lead

NCT05831345Phase 3Recruiting

Intraoperative Methadone for the Prevention of Postoperative Pain

Role: lead

NCT02815696Not ApplicableCompleted

MRI Analysis of Glycosaminoglycan Modifications Inside the Intervertebral Disk After Distraction and Posterior Fusion

Role: lead

NCT05667857Not ApplicableRecruiting

Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy

Role: collaborator

NCT06160232Phase 2Recruiting

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder

Role: lead

NCT05913518Not ApplicableRecruiting

Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study

Role: lead

NCT06412822Recruiting

Neutrophil Extracellular Traps (NET's) in Prevalent Kidney Stone

Role: lead

NCT04034875Not ApplicableCompleted

Questionnaire for the Evaluation of Anger, Hostility and Aggression After Acquired Brain Injury.

Role: lead

NCT06347029Not ApplicableRecruiting

Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies

Role: lead

NCT06296160Not ApplicableRecruiting

A Simplified Lung Ultrasound Guided Management Protocol Of Pulmonary Congestion in Hemodialysis

Role: collaborator

NCT06257251Recruiting

Silicone Particles in Breast Implant Capsules

Role: lead

NCT05490602Active Not Recruiting

Comparison Study in Different Sutures Techniques in Reduction of Known Abdominoplasty Complications and Improving Patients' Post-operative Outcomes

Role: lead

NCT06112821Unknown

Arteriovenous Fistula Maturation in Hemodialysis Patients With or Without Positive Antiphospholipid Antibodies

Role: lead

NCT06067867Recruiting

Kidney and Pregnancy Registry

Role: lead

NCT02803502Not ApplicableUnknown

Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?

Role: lead